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Abstract
ATP-activated P2X3 receptors expressed in nociceptive sensory neurons play an important role
in pain signaling. Basic properties of this receptor subtype, including very strong desensitization,
depend on the rate of dissociation of the agonist from the binding site. Even though the rough
structure of the ATP binding site has been proposed on the basis of the X-ray structure of the
zebrafish P2X4 receptor and mutagenesis studies, the fine subunit-specific structural properties
predisposing the receptor to tight capture of the agonist inside the binding pocket have not
been elucidated. In this work, by exploring in silico the functional role for the left flipper located
in the ectodomain region, we identified within this loop a candidate residue S275, which could
contribute to the closure of the agonist-binding pocket. Testing of the S275 mutants using the
patch-clamp  technique  revealed  a  crucial  role  for  S275  in  agonist  binding  and  receptor
desensitization.  The S275A mutant showed a reduced rate of  onset of  desensitization and
accelerated  resensitization  and  was  weakly  inhibited  by  nanomolar  agonist.  Extracellular
calcium application produced inhibition instead of facilitation of membrane currents. Moreover,
some full agonists became only partial agonists when applied to the S275A receptor. These
effects were stronger with the more hydrophobic mutants S275C and S275V. Taken together,
our data suggest that S275 contributes to the closure of the agonist-binding pocket and that
effective capture of  the agonist  provided by the left  flipper  in  calcium-dependent  manner
determines the high rate of desensitization, slow recovery, and sensitivity to nanomolar agonist
of the P2X3 receptor. © 2011 American Chemical Society.
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